OMRON initiates AI-based hypertension & ECG remote monitoring trial

OMRON Healthcare India has initiated a pathbreaking AI-based hypertension and ECG remote monitoring collaborative trial with Tricog and Sakra World Hospital

0
60
New Delhi: OMRON Healthcare India, the leading player in the digital home blood pressure monitoring segment, has announced the initiation of India’s first-of-its-kind AI-based collaborative trial program in the field of remote patient monitoring. The program, targeted at patients that have undergone surgical procedures or ablation for the treatment of cardiovascular diseases, aims to establish the relevance and role of remote hypertension and ECG monitoring for strengthening the treatment and care regime to reduce cardiovascular complications and deaths.
According to worldwide surveys on human atrial fibrillation, around 27% of the patients experience recurrence of atrial fibrillation (AFib) after ablation treatment. This underlines the importance of real-time and continuous monitoring of ECG along with blood pressure at home in order to help the doctors take more informed and timely decisions.
“OMRON aims to expand its presence in the remote patient monitoring segment which is gaining lot of significance in the healthcare ecosystem of India. Post collaborating with varied AI based healthcare applications in the personal healthcare monitoring domain, we are all set to move ahead and strengthen our value addition in the hospital care management with this endeavor. With the right partners on board, we are optimistic of receiving good results from the trial. It will help us to propel ahead our vision of ‘Going for Zero’ cardiovascular diseases by collaborating OMRON’s vital sensing technology with AI of Tricog & doctors’ support at Sakra World Hospital,” said Masanori Matsubara, MD, OMRON Healthcare India.
The study in the trial will explore two core possibilities – how technology can enable monitoring of ECG at home and how AI can enable timely intervention in the postoperative cardiovascular patients. The aim is to achieve further improvement of cardiovascular disease management coupled with high blood pressure management in a remote environment.